top of page

Safety considerations in therapeutic genome editing

Toni Cathomen, University of Freiburg

Toni Cathomen is Director of the Institute for Transfusion Medicine and Gene Therapy at the Medical Center of the University of Freiburg, Germany. His research activities focus on developing cell therapies based on induced pluripotent stem cells (iPSCs), improving the effectiveness and safety of designer nucleases (CRISPR-Cas and TALEN), and developing and manufacturing genome edited stem cell and immune cell preparations for the treatment of HIV infection, primary immunodeficiencies and cancer.

bottom of page